Defaulting from anti-tuberculosis treatment in a teaching hospital in Rio de Janeiro, Brazil

Int J Tuberc Lung Dis. 2004 Mar;8(3):318-22.

Abstract

Setting: Few studies have investigated factors associated with defaulting from anti-tuberculosis (TB) therapy in hospital settings.

Objective: To identify the factors associated with defaulting from treatment among TB in-patients in Rio de Janeiro city, Brazil.

Design: Case-control study.

Methods: All study participants initiated anti-tuberculosis treatment in a teaching hospital. A defaulting case was defined as a person who did not return for anti-tuberculosis medications after 60 days. Cases and controls were interviewed by a trained health care worker using a standardized form.

Results: From 1 January to 31 December 1997, 228 TB cases were registered. After a review of the medical records, 39 were excluded. Household visits were performed in 189 patients; 46 subjects were identified as cases and 117 as controls. Defaulting from anti-tuberculosis treatment was observed in 66 cases (28.9%) before and in 46 (20.2%) after a home visit. After multivariate analysis, the strongest predictors of defaulting from treatment were: 1) returning card not provided (OR 0.099; 95%CI 0.008-1.2; P = 0.07), 2) not feeling comfortable with a doctor (OR 0.16; 95%CI 0.33-0.015; P = 0.001), and 3) blood pressure not measured (OR 0.072; 95%CI 0.036-0.79; P = 0.024).

Conclusions: In this hospital, the factors associated with defaulting from anti-tuberculosis treatment highlight the necessity for a structured TB Control Program. It is expected that the implementation of such a program, pursuing specific approaches, should enhance completion of anti-tuberculosis treatment and cure.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Brazil
  • Case-Control Studies
  • Female
  • Hospitals, Teaching
  • Humans
  • Male
  • Outpatient Clinics, Hospital
  • Process Assessment, Health Care
  • Risk Factors
  • Socioeconomic Factors
  • Treatment Refusal*
  • Tuberculosis / drug therapy*